Company Overview of CellGenTech, Inc.
CellGenTech, Inc. engages in the research and development of drugs for new gene therapy and regenerative medicine. It offers adipocyte-based medicine/technology for the development of gene/cell therapies. The company provides protein supplemental therapy solutions in the areas of hereditary diseases; orphan diseases; intractable diseases, such as lysosome and hemophilia; diabetics; and arteriosclerotic disease, and cancer or degenerative neuropathies. CellGenTech, Inc. was founded in 2003 and is based in Chiba, Japan.
Chiba-dai Inohana Innovation Plaza #101
Founded in 2003
81 434 41 4121
81 434 41 4121
Key Executives for CellGenTech, Inc.
Similar Private Companies By Industry
|Amano Enzyme Inc.||Asia|
|ArBlast Co., Ltd.||Asia|
|Bio Matrix Research, Inc.||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact CellGenTech, Inc., please visit www.cellgentech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.